KLRS

Kalaris Therapeutics, Inc. Common Stock

75 hedge funds and large institutions have $600M invested in Kalaris Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 10 reducing their positions, and 10 closing their positions.

Holders
75
Holders Change
+4
Holders Change %
+5.63%
% of All Funds
1.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
38
Reduced
10
Closed
10
Calls
$5.24M
Puts
$44K
Net Calls
+$5.2M
Net Calls Change
+$5.18M
Name Holding Trade Value Shares
Change
Shares
Change %
Norges Bank
76
Norges Bank
Norway
-$1.92M -2,174 Closed
DnB Asset Management
77
DnB Asset Management
Norway
-$1.15M -1,306 Closed
SFI
78
Susquehanna Fundamental Investments
Pennsylvania
-$898K -1,016 Closed
MS
79
Maven Securities
Jersey
-$799K -865 Closed
JG
80
Jefferies Group
New York
-$630K -713 Closed
GGHC
81
Gilder Gagnon Howe & Co
New York
-$509K -575 Closed
Allianz Asset Management
82
Allianz Asset Management
Germany
-$301K -340 Closed
Qube Research & Technologies (QRT)
83
Qube Research & Technologies (QRT)
United Kingdom
-$240K -272 Closed
TWA
84
TCI Wealth Advisors
Arizona
-$1K -1 Closed